Tuesday, November 24, 2020
Home Life Style Health & Fitness Drugs Treating BP Don't Increase Risk of Covid: Study

Drugs Treating BP Don’t Increase Risk of Covid: Study

Common BP drugs don't increase risk of Covid-19 severity

Researchers have revealed that a widely used class of drugs to treat patients with hypertension, cardiovascular disease and diabetic kidney disease does not increase the risk of developing a severe Covid-19 infection as previously feared.

There have been concerns by the medical community worldwide that the drugs — ACE inhibitors and angiotensin receptor blockers (ARB) — might have caused an increase in ACE2, the main receptor for SARS-CoV-2, which could possibly increase the risk for this infection and its severity.

Follow NewsGram on Instagram to keep yourself updated.

But the new findings, published in the journal of the American Society of Nephrology, revealed a decrease in ACE2 in mice kidney membranes and no change in lung membranes.

Common BP drugs don't increase risk of Covid-19 severity
Drugs to treat patients with hypertension does not increase the risk of developing a severe Covid-19. Pixabay

“This study supports the concept that there is no increased risk for Covid-19 infection by using ACE inhibitors and angiotensin receptor blockers,” said study researcher Daniel Batlle from the Northwestern University in the US.

For the findings, the research team examined the effect of ACE2 and ARBs in the lungs, which are considered one of the main targets for SARS-CoV-2 entry into the body.

ACE inhibitors and ARBs are a category of drugs called RAS blockers.

These drugs, by different mechanisms, block the actions of a peptide that causes narrowing of blood vessels and fluid retention by the kidneys, which result in increased blood pressure.

The drugs help c relax and expand and decrease fluid retention, both of which lower blood pressure.

To examine this issue, the team measured ACE2 in isolated kidney and lung membranes of mice that were treated with either captopril, a widely used ACE inhibitor, or telmisartan, an ARB also widely prescribed.

Common BP drugs don't increase risk of Covid-19 severity
The drugs help c relax and expand and decrease fluid retention, both of which lower blood pressure. Pixabay

Since the recognition that ACE2 is the main receptor for SARS-CoV-2, there have been multiple studies discussing the potential risk for susceptibility and worse clinical course of Covid-19 in patients treated with RAS blockers.

Also Read: A New Gadget Category For Women

Much of the speculation comes from previous animal studies where some RAS blockers were reported to upregulate ACE2 in the heart and kidney vasculature.

“My lab has long worked with ACE2, and this was a critical question that needed to be addressed,” Batlle said.

“We had no bias one way or another, and the kidney findings showing lower ACE2 in treated animals were a bit unexpected,” the authors wrote. (IANS)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,781FollowersFollow

Most Popular

Why Should You Organize A Trivia Night Out With A Trivia Board Game?

Everyone loves game nights, and when it's a trivia night out, you and your loved ones will have more knowledge about at least one...

The Sporting Greats

By Samantha Many millennials grew up watching football, and to be honest, the game has evolved since it started centuries ago. But when we turn...

Here’s Why Antibiotics Increase Risks of Heart Attacks

Researchers have explained why commonly used antibiotics like clarithromycin can lead to an increased risk of heart attacks, opening up the possibility of precision...

The Unstoppable Growth Of TikTok And Amateur Content Creation

By Mitchel Russo The amount of time we spend in front of our phones is growing, indeed that growth has skyrocketed during the recent COVID-19...

Lachit Divas: Untold Story Of Hero Lachit Borphukan

We have heard a lot about the valor of Shivaji, Bajirao, and others, but not much is known about the Ahoms. In 1682, the...

List Of New Cabinet Members Selected By U.S. President Joe Biden

U.S. President-elect Joe Biden has begun naming members of his new Cabinet, as well as other top-level administration officials. Biden has pledged to choose...

India Sees Consecutive Year-On-Year Decline In Coal Funding: Report

The third annual Coal vs Renewable Financial Analysis 2019 marks a second consecutive year-on-year decline in coal funding in India following a 90 percent...

Mobile Fingerprinting App Becomes A Core Tool In Deportation Crackdown

A mobile fingerprinting app U.S. immigration agents use to run remote ID checks in the field has become a core tool in President Donald...

Recent Comments